)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Episurf Medical
Episurf Medical (EPIS) investor relations material
Episurf Medical Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary24 Aug, 2026
Executive summary
Transitioned from a medtech company to a Nordic real estate platform focused on stable cash flows and scale advantages.
Major acquisitions of property portfolios, including Mofast and KlaraBo, increased property value and earnings capacity.
Strategic decision to wind down medtech operations and focus resources on real estate.
Financial highlights
Rental income rose 257% year-over-year to SEK 17.5m for H1 2026; operating profit up 254% to SEK 13.1m.
Net result after tax was SEK -234m, impacted by SEK -162.4m goodwill impairment and SEK -20.1m property revaluation.
Cash flow from operations before working capital changes was SEK -44.4m.
Property investments totaled SEK 969m, mainly from acquisitions.
Outlook and guidance
Targeting SEK 10bn in underlying property value by year-end 2026.
Pro forma property assets expected to reach SEK 5.9bn with annual rental income of SEK 496m and occupancy of 94.3%.
Continued focus on disciplined growth and improved financing terms as scale increases.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Episurf Medical
- Transformation to a property-focused company drove strong sales growth but higher losses.EPIS
Q1 2026 - Q4 2025 saw higher order intake, U.S. growth, and a transformative real estate acquisition.EPISQ4 2025
- US growth and cost savings drive improved results, but financing uncertainty persists.EPISQ3 2025
- Adjusted EBIT improved, U.S. order intake surged, and a SEK 29.4m rights issue is planned.EPISQ2 2025
- Q3 saw improved results, US expansion, and strong order growth; 510(k) clearance expected 2025.EPISQ3 2024
- Strong sales growth and improved losses as US expansion and cost savings accelerate.EPISQ2 2024
- Record Q1 sales and US growth position Episurf for accelerated expansion and improved results.EPISQ1 2025
- Cash flow improved, losses narrowed, and US and EU distribution expanded in 2024.EPISQ4 2024
Next Episurf Medical earnings date
Q3 202620 Nov, 2026
Episurf Medical
Next Episurf Medical earnings date
Q3 202620 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Episurf Medical AB, a medical device company, designs and manufactures implants and surgical instruments. The company offers polyurethane foam products, including foam for sinus augmentation and reconstruction, as well as foam for other uses. It also provides polyurethane foam instruments for the delivery of bone morphogenetic protein product for orthopedic applications. In addition, the company is engaged in the research and development of new products targeting at cervical spine applications. The company is based in Stockholm, Sweden.